002880.SZ
Shenzhen Weiguang Biological Products Co., Ltd.
SZSE · Healthcare · C 制造业 · CN
CNY 20.50
−2.94%Margins
Gross margin
38.8%
EBITDA margin
35.0%
EBIT margin
21.4%
Net margin
18.5%
FCF margin
-3.2%
9.6%
Return on equity
6.4%
Return on assets
8.4%
Return on invested capital
0.34x
Asset turnover
CNY 124.4M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026